EVALUATION OF THE USE OF REDUCED DOSE OF RITUXIMAB IN IMMUNE THROMBOCYTOPAENIAR. Jimenez Barcenas, S. Flores Moreno,R. Nunez Vazquez,F. J. Rodriguez Martorell,J. A. Perez SimonHAEMATOLOGICA(2019)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要